OF DATA MANAGEMENT AND STATISTICS CORE The Data Management and Statistics Core (DSMC) of the Yale ADRC will provide data management and statistical support to meet the operational needs and research. The Yale DMSC will be led by Heather Allore, Ph.D. and Peter Charpentier, M.P.H. who are the directors of the Biostatics and the Data Management and Informatics Cores, respectively, of the Yale Program on Aging (POA) and of the Claude D. Pepper Older Americans Independence Center at Yale. The statistical and data management methodologies proposed for Yale DMSC are based on practices and systems developed and implemented at POA and Yale's Clinical and Translational Science Institute- the Yale Center for Clinical Investigations (YCCI) - that sponsors a special implementation of the Oncore Clinical Trial Management System. The Yale DMSC will leverage the computing and resource infrastructure provided by POA and YCCI. The DSMC will develop appropriate data management systems and procedures for subject tracking, accrual and other conduct-of-study reports, and secure storage of ePHI. This includes the creation and management of case report forms (CRFs) for all clinical data, as well as electronic spreadsheets for basic neuroscience laboratories and some clinical research projects, and a suitable procedure for UDS data management. Throughout these procedures secure, HIPAA-compliant data management practices will be employed. The DMSC will interact with other Cores to manage data and provide statistical consultation and educational and outreach program evaluation. Furthermore, the ADRC will provide research and pilot projects statistical and analysis files will be created on a de-identified SAS data mart . Together these activities of the DSMC will ensure robust data management and statistical analysis throughout the Yale ADRC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG047270-02
Application #
9086183
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Scherer, Roberta W; Drye, Lea; Mintzer, Jacobo et al. (2018) The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials 19:46
Strittmatter, Stephen M (2018) Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications. Biol Psychiatry 83:298-299
Mecca, Adam P; Barcelos, Nicole M; Wang, Shuo et al. (2018) Cortical ?-amyloid burden, gray matter, and memory in adults at varying APOE ?4 risk for Alzheimer's disease. Neurobiol Aging 61:207-214
Gill, Thomas M; Han, Ling; Leo-Summers, Linda et al. (2018) Distressing Symptoms, Disability, and Hospice Services at the End of Life: Prospective Cohort Study. J Am Geriatr Soc 66:41-47
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487

Showing the most recent 10 out of 134 publications